Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Metrochem Dapagliflozin

    Virtual Booth

    Contact Supplier

    CHSD Dapagliflozin

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Dapagliflozin

    Virtual Booth

    Contact Supplier

    Dapagliflozin

    Virtual Booth

    Contact Supplier

    Menu

    (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,639Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2AIZANT

    02 2APOTEX INC

    03 13ASTRAZENECA AB

    04 1AUROBINDO PHARMA LIMITED

    05 2GLENMARK GENERICS

    06 2HETERO LABS UNIT III

    07 2JIANGSU HANSOH PHARM

    08 2LUPIN LTD

    09 4MACLEODS PHARMACEUTICALS LTD

    10 2MSN LABORATORIES PRIVATE LTD

    11 1MSN LABS PVT LTD

    12 4SINOTHERAPEUTICS INC

    13 2TEVA PHARMS USA INC

    14 2ZYDUS PHARMS

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN

    Brand Name : FARXIGA

    Dosage Form : TABLET;ORAL

    Dosage Strength : 5MG

    Approval Date : 2014-01-08

    Application Number : 202293

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN

    Brand Name : FARXIGA

    Dosage Form : TABLET;ORAL

    Dosage Strength : 10MG

    Approval Date : 2014-01-08

    Application Number : 202293

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

    Brand Name : XIGDUO XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 5MG;500MG

    Approval Date : 2014-10-29

    Application Number : 205649

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

    Brand Name : XIGDUO XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 5MG;1GM

    Approval Date : 2014-10-29

    Application Number : 205649

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

    Brand Name : XIGDUO XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 10MG;500MG

    Approval Date : 2014-10-29

    Application Number : 205649

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

    Brand Name : XIGDUO XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 10MG;1GM

    Approval Date : 2014-10-29

    Application Number : 205649

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE

    Brand Name : XIGDUO XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 2.5MG;1GM

    Approval Date : 2017-07-28

    Application Number : 205649

    RX/OTC/DISCN : RX

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : QTERN

    Dosage Form : TABLET;ORAL

    Dosage Strength : 10MG;EQ 5MG BASE

    Approval Date : 2017-02-27

    Application Number : 209091

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : QTERN

    Dosage Form : TABLET;ORAL

    Dosage Strength : 5MG;EQ 5MG BASE

    Approval Date : 2019-05-02

    Application Number : 209091

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    ASTRAZENECA AB

    United Kingdom
    Aus. Peptide Conference
    Not Confirmed
    arrow

    ASTRAZENECA AB

    United Kingdom
    arrow
    Aus. Peptide Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RLD : Yes

    TE Code :

    DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE

    Brand Name : QTERNMET XR

    Dosage Form : TABLET, EXTENDED RELEASE;ORAL

    Dosage Strength : 2.5MG;1GM;EQ 2.5MG BASE

    Approval Date : 2019-05-02

    Application Number : 210874

    RX/OTC/DISCN : DISCN

    RLD : Yes

    TE Code :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF